Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

Aug 01, 2019

|

This story has been updated with additional details from UnitedHealthcare's coverage policy.

NEW YORK – UnitedHealthcare has issued a positive coverage decision for Myriad Genetics' GeneSight Psychotropic pharmacogenetic test, Myriad disclosed in a filing with the US Securities and Exchange Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

To read the full story....

Breaking News

In Brief This Week: Qiagen, Yourgene, Beckman Coulter Life Sciences, and More

Oxford Nanopore Technologies Raises £48.4M in Private Financing

Quest Diagnostics Receives FDA Emergency Use Authorization for COVID-19 Self-Collection Test Kit

Biolytical Awarded C$633K to Develop One-Minute COVID-19 Antibody Test

AACC Sends Testing Recommendations to Senate For SARS-CoV-2 Relief Bill

Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing

What's Popular?

Coronavirus Antibody Test Distribution Deal Inked by MedMira, Webb Diagnostic

Biolytical Awarded C$633K to Develop One-Minute COVID-19 Antibody Test

Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

Trinity Biotech Posts 4 Percent Drop in Q1 Revenues

Xiamen Wiz Biotech Rapid Coronavirus Immunoassay Kit Gets CE Mark

Sponsorships